» Articles » PMID: 2062845

DNA Looping and Sp1 Multimer Links: a Mechanism for Transcriptional Synergism and Enhancement

Overview
Specialty Science
Date 1991 Jul 1
PMID 2062845
Citations 96
Authors
Affiliations
Soon will be listed here.
Abstract

Using conventional and scanning transmission electron microscopy, we have examined the physical basis of long-range enhancer effects between distal and proximal elements in a eukaryotic promoter. Specifically, we have studied binding of human transcription factor Sp1 to 10-base-pair G+C-rich elements ("GC boxes") located at -100 and +1700 relative to the RNA start site. It was previously observed that the distantly located site functions in synergism with the promoter-proximal site to strongly activate transcription in vivo. Here we demonstrate that this synergism is likely to be a direct consequence of interactions between remote and local Sp1, the remote Sp1 translocated to the promoter by a DNA loop. Scanning transmission electron microscopy shows that Sp1 initially forms a tetramer and subsequently assembles multiple tetramers stacked in register at the DNA loop juncture. This unexpected finding not only provides the physical basis for loop formation but also defines a biological process leading to strongly increased concentration of activator protein at the promoter. The mechanism may unify the problem of transcriptional activation by removing enhancer action as a separate class of regulatory activity.

Citing Articles

YAP/TEAD4/SP1-induced VISTA expression as a tumor cell-intrinsic mechanism of immunosuppression in colorectal cancer.

Zhu Z, Ding R, Yu W, Liu Y, Zhou Z, Liu C Cell Death Differ. 2025; .

PMID: 39875519 DOI: 10.1038/s41418-025-01446-2.


Role of post-translational modifications of Sp1 in cancer: state of the art.

Sun X, Xiao C, Wang X, Wu S, Yang Z, Sui B Front Cell Dev Biol. 2024; 12:1412461.

PMID: 39228402 PMC: 11368732. DOI: 10.3389/fcell.2024.1412461.


Role of Specificity Protein 1 (SP1) in Cardiovascular Diseases: Pathological Mechanisms and Therapeutic Potentials.

Ding J, Fayyaz A, Ding Y, Liang D, Luo M Biomolecules. 2024; 14(7).

PMID: 39062521 PMC: 11274404. DOI: 10.3390/biom14070807.


Identification of mechanism of cancer-cell-specific reactivation of hTERT offers therapeutic opportunities for blocking telomerase specifically in human colorectal cancer.

Akincilar S, Chua J, Ng Q, Chan C, Eslami-S Z, Chen K Nucleic Acids Res. 2022; 51(1):1-16.

PMID: 35697349 PMC: 9841410. DOI: 10.1093/nar/gkac479.


Enhancer-gene specificity in development and disease.

Pachano T, Haro E, Rada-Iglesias A Development. 2022; 149(11).

PMID: 35686641 PMC: 7612879. DOI: 10.1242/dev.186536.


References
1.
Moitoso de Vargas L, Pargellis C, Hasan N, Bushman E, Landy A . Autonomous DNA binding domains of lambda integrase recognize two different sequence families. Cell. 1988; 54(7):923-9. DOI: 10.1016/0092-8674(88)90107-9. View

2.
Mukherjee S, Erickson H, Bastia D . Enhancer-origin interaction in plasmid R6K involves a DNA loop mediated by initiator protein. Cell. 1988; 52(3):375-83. DOI: 10.1016/s0092-8674(88)80030-8. View

3.
Courey A, Tjian R . Analysis of Sp1 in vivo reveals multiple transcriptional domains, including a novel glutamine-rich activation motif. Cell. 1988; 55(5):887-98. DOI: 10.1016/0092-8674(88)90144-4. View

4.
Kadonaga J, Courey A, Ladika J, Tjian R . Distinct regions of Sp1 modulate DNA binding and transcriptional activation. Science. 1988; 242(4885):1566-70. DOI: 10.1126/science.3059495. View

5.
Janin J, Miller S, Chothia C . Surface, subunit interfaces and interior of oligomeric proteins. J Mol Biol. 1988; 204(1):155-64. DOI: 10.1016/0022-2836(88)90606-7. View